America’s China Licensing Regime Now Helps Beijing

The U.S. export licensing system for China has become a self-defeating mechanism that harms American businesses while failing to prevent technology transfers, according to a recent industry survey.

A survey conducted by the U.S.-China Business Council (USCBC) in July found that 82 percent of member firms in technology, industrial manufacturing, energy, and healthcare reported delays in obtaining export licenses for goods already available in China. These delays, often lasting months or even years, have led to lost deals and market share for American companies. Seventy-three percent of respondents lost business to Chinese competitors while awaiting approval, while 55 percent lost orders to non-Chinese rivals with faster supply chains. More than a third reported losses in the tens of millions of dollars or higher.

The USCBC report highlights that the current licensing process is not effectively protecting sensitive technology but is instead undermining U.S. competitiveness. Sean Stein, USCBC president, stated that poorly calibrated export controls "have the reverse effect," harming U.S. technological leadership without advancing national security goals.

The delays have real-world consequences. For example, Samsung and SK Hynix, which operate chip fabrication plants in China, faced prolonged license reviews in 2025 after Washington revoked their validated end-user status. The companies spent months applying for annual licenses instead, creating uncertainty and prompting them to explore alternative suppliers. While neither firm has yet shifted production at scale, the option now exists—effectively weakening reliance on U.S. equipment.

The Commerce Department’s own enforcement has also been inconsistent. In June, it admitted failing to restrict high-end AI chips for over a year, later approving licenses for Nvidia’s H200 chip in limited quantities despite prior denials. By August, the first shipments arrived, months after Chinese regulators had already approved large-scale purchases by companies like ByteDance and Tencent.

The broader impact extends beyond individual firms. The U.S. licensing regime’s inefficiency is reshaping supply chains across Asia, as companies in South Korea, Japan, and Taiwan adapt to prolonged delays by diversifying suppliers. Meanwhile, China has weaponized its own export controls, tightening rare earth licensing in 2025 and adding U.S. firms to its control list. Beijing treats licensing as a diplomatic tool, while Washington’s system appears to operate by inertia rather than strategic intent.

A critical test looms on November 10, when automatic restrictions on companies 50 percent owned by blacklisted Chinese entities are set to resume unless the Commerce Department intervenes. If allowed to take effect, the policy will likely exacerbate market losses for U.S. exporters while pushing allies toward alternative supply chains.

Analysts argue that the current system achieves little beyond subsidizing Chinese competitors. With 66 percent of pending licenses exceeding the 90-day statutory review window—some pending for one to two years—the process is undermining the very industries it claims to protect. Unless the Commerce Department acts to separate legitimate national security concerns from routine commercial transactions, the U.S. risks ceding further ground to foreign rivals without securing any strategic advantage.